These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 4358224

  • 1. Potential antidiabetic agents. Pyrazolo(3,4-b)pyridines.
    Höhn H, Polacek I, Schulze E.
    J Med Chem; 1973 Dec; 16(12):1340-6. PubMed ID: 4358224
    [No Abstract] [Full Text] [Related]

  • 2. 1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases.
    Chasin M, Harris DN, Phillips MB, Hess SM.
    Biochem Pharmacol; 1972 Sep 15; 21(18):2443-50. PubMed ID: 4345859
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation and antidiabetic activity of new 3-methyl-5-phenylpyrazolesulfonylurea derivatives.
    Soliman R, Feid-Allah HM.
    J Pharm Sci; 1981 Jun 15; 70(6):602-5. PubMed ID: 6788934
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of some isoquinoline compounds and certain derivatives on brain phosphodiesterase activity.
    Furlanut M, Carpenedo F, Ferrari M.
    Biochem Pharmacol; 1973 Oct 15; 22(20):2642-4. PubMed ID: 4357892
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z, Magiełka S, Wójcikowski C.
    Acta Pol Pharm; 1983 Oct 15; 40(2):134-8. PubMed ID: 6659996
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.
    Cottineau B, Toto P, Marot C, Pipaud A, Chenault J.
    Bioorg Med Chem Lett; 2002 Aug 19; 12(16):2105-8. PubMed ID: 12127514
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
    Harris DN, Chasin M, Phillips MB, Goldenberg H, Samaniego S, Hess SM.
    Biochem Pharmacol; 1973 Jan 15; 22(2):221-8. PubMed ID: 4357795
    [No Abstract] [Full Text] [Related]

  • 15. Sulfonylureas and the heart.
    Levey GS, Lasseter KC, Palmer RF.
    Annu Rev Med; 1974 Jan 15; 25():69-74. PubMed ID: 4363211
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M, Harris DN.
    Adv Cyclic Nucleotide Res; 1976 Jan 15; 7():225-64. PubMed ID: 188316
    [No Abstract] [Full Text] [Related]

  • 17. Effect of glucagon, dibutyryl adenosine 3',5'-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3',5'-cyclic monophosphate levels.
    Ingebretsen C, Clark JF, Allen DO, Ashmore J.
    Biochem Pharmacol; 1974 Aug 15; 23(15):2139-46. PubMed ID: 4369954
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E, Marin A, Verdejo F, Sanchez MS, Morell J.
    Boll Chim Farm; 1975 Jul 15; 114(7):379-92. PubMed ID: 1164447
    [No Abstract] [Full Text] [Related]

  • 20. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K, Schröder E, Rufer C, Loge O.
    Arzneimittelforschung; 1974 Jul 15; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.